Information Journal Paper
APA:
Copy. (2020). Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. AGING AND DISEASE, 11(2), 0-0. SID. https://sid.ir/paper/776056/en
Vancouver:
Copy. Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. AGING AND DISEASE[Internet]. 2020;11(2):0-0. Available from: https://sid.ir/paper/776056/en
IEEE:
Copy, “Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia,” AGING AND DISEASE, vol. 11, no. 2, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/776056/en